New clinical trial for adrenoleukodystrophy, a rare disease of brain metabolism

by Hospital Universitari de Bellvitge

2 years ago
adrenoleukodystrophy, clinical trial, Neurometabolic Diseases

The IDIBELL Neurometabolic Diseases team, which is also part of CIBERER, plans to start the study in early 2022 with the anti-inflammatory dimethyl fumarate in patients with this condition. The study...

OncoDNA provides strategic support in Radiomics' prospective clinical trial SALMON

by OncoDNA

2 years ago
Radiomics, OncoDNA, cancer biomarkers, technology, IA, clinical trial, SALMON

Radiomics and OncoDNA are pleased to announce that they have entered into a strategic agreement, combining Radiomics’ next-generation AI-based technology to extract quantitative information embedded...

Palobiofarma announces positive results in the Phase IIa clinical trial evaluating it´s first in class investigational treatment PBF-677 in patients with mild to moderate ulcerative colitis

by Palobiofarma

2 years ago
Ulcerative Colitis, clinical trial

The Phase II trial studied the safety, tolerability, and preliminary efficacy of PBF-677 in patients with mild to moderate Ulcerative Colitis in flair condition on top of the standard of care Mesalazi...

Archivel Farma is proud to announce the recruitment of the first patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB)

by Asebio

3 years ago
STriTuVaD, Archivel Farma, AGMC, AIIMS, Tuberculosis, Vaccine, Clinical Trial

The clinical trials will be conducted in two centers in India: the All India Institute Of Medical Sciences (AIIMS) of New Delhi, and the Agartala Government Medical College of Agartala

ORYZON enrolls first patient in the US in PORTICO, a Phase IIb clinical trial with vafidemstat in Borderline Personality Disorder

by Oryzon Genomics

3 years ago
Oryzon Genomics, PORTICO, Vafidemstat, clinical trial, Borderline Personality Disorder

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...

Oryzon announces $1 million grant from Kabuki syndrome philanthropists to support a precision medicine Phase I/II trial with vafidemstat

by Oryzon Genomics

3 years ago
Kabuki Syndrome Foundation, Vafidemstat, Oryzon Genomics, clinical trial

ORYZON receives approval to start EVOLUTION Phase IIb trial with vafidemstat in schizophrenia

by Oryzon Genomics

3 years ago
Vafidemstat, Oryzon Genomics, biopharmaceutical, Clinical Trial, schizophrenia

Launch of a pioneering clinical trial to validate the efficacy of immunotherapy in 29 types of tumour

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
clinical trial, ACROPOLI, immunotherapy, Biomarker, Cancer, SOLTI

The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 29 different types of cancer simultaneously.

A clinical trial with calcitriol has begun to validate its therapeutic potential for treating Friedreich's Ataxia

by IRB Lleida. Institut de Recerca Biomèdica

3 years ago
Friedreich's ataxia, neurodegenerative disease, clinical trial

Friedreich's ataxia is a minority neurodegenerative disease characterised by difficulty in coordinating movements

VHIO is participating prominently in a study that seeks to evaluate the efficacy of a novel combination therapy in advanced pancreatic cancer

by Vall d’Hebron

3 years ago
ABTL0812, Ability Pharmaceuticals, clinical trial, pancreatic cancer

The biopharmaceutical company Ability Pharmaceuticals, SL today announced the inclusion of the first patients in a phase 2b clinical trial with its novel autophagy-inducer anticancer compound ABTL0812...